The Committee for Human Use (CHMP) of the EMEA has recommended in its meeting of February 2011, restricting the use of stavudine.
stavudine (Zerit, BMS) should be used only as short as possible and only when no therapeutic alternatives are available for adults and children.
Source:
Press release of 18 EMA February 2011
0 comments:
Post a Comment